N-(2-(1,3-BENZODIOXOL-5-YL)ETHYL)-1-(2-IMIDAZOL-1-YL-6-METHYLPYRIMIDIN-4-YL)PYRROLIDINE-2-CARBOXAMIDE, (2R)-
UNII RT8DF4MCG2
Substance Identification & Data
This profile provides standardized clinical and technical data for N-(2-(1,3-benzodioxol-5-yl)ethyl)-1-(2-imidazol-1-yl-6-methylpyrimidin-4-yl)pyrrolidine-2-carboxamide, (2r)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RT8DF4MCG2.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 402934-09-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H24N6O3 LBCGUKCXRVUULK-QGZVFWFLSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-(2-(1,3-benzodioxol-5-yl)ethyl)-1-(2-imidazol-1-yl-6-methylpyrimidin-4-yl)pyrrolidine-2-carboxamide, (2r)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.